Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

motexafin gadolinium

(moh-TEK-suh-fin GA-doh-LIH-nee-um)
A substance being studied in the treatment and diagnosis of some types of cancer. It builds up in some cancer cells, which may make them easier to kill with radiation therapy and chemotherapy. Motexafin gadolinium is also used in magnetic resonance imaging (MRI) to help find cancer cells in the body. It is a type of radiosensitizing agent, a type of chemosensitizing agent, and a type of contrast agent. Also called gadolinium texaphyrin.
Search NCI's Dictionary of Cancer Terms